Scientific and Regulatory Policy Committee Points to Consider: Primary Digital Histopathology Evaluation and Peer Review for Good Laboratory Practice (GLP) Nonclinical Toxicology Studies

Author:

Forest Thomas1ORCID,Aeffner Famke2ORCID,Bangari Dinesh S.3ORCID,Bawa Bhupinder4ORCID,Carter Jonathan5,Fikes James6ORCID,High Wanda7ORCID,Hayashi Shim-mo89,Jacobsen Matthew10ORCID,McKinney LuAnn11,Rudmann Daniel12ORCID,Steinbach Thomas13ORCID,Schumacher Vanessa14ORCID,Turner Oliver15ORCID,Ward Jerrold M.16ORCID,Willson Cynthia J.17ORCID

Affiliation:

1. Merck & Co., Inc., West Point, Pennsylvania, USA

2. Amgen, Inc., South San Francisco, California, USA

3. Sanofi R&D, Framingham, Massachusetts, USA

4. AbbVie, Inc., North Chicago, Illinois, USA

5. Labcorp Early Development Laboratories Ltd, Harrogate, UK

6. Biogen, Inc., Cambridge, Massachusetts, USA

7. High Preclinical Pathology Consulting, Rochester, New York, USA

8. Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, Fuchu, Tokyo, Japan

9. Division of Food Additives, National Institute of Health Sciences, Kawasaki, Kanagawa, Japan

10. Regulatory Safety Centre of Excellence, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK

11. Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA

12. Charles River Laboratories International, Inc., Wilmington, Massachusetts, USA

13. Experimental Pathology Laboratories, Inc., Research Triangle Park, North Carolina, USA

14. F. Hoffmann-La Roche, Ltd, Basel, Switzerland

15. Novartis, East Hanover, New Jersey, USA

16. GlobalVetPathology, Montgomery Village, Maryland, USA

17. Integrated Laboratory Systems, Research Triangle Park, North Carolina, USA

Abstract

The Society of Toxicologic Pathology’s Scientific and Regulatory Policy Committee formed a working group to consider the present and future use of digital pathology in toxicologic pathology in general and specifically its use in primary evaluation and peer review in Good Laboratory Practice (GLP) environments. Digital histopathology systems can save costs by reducing travel, enhancing organizational flexibility, decreasing slide handling, improving collaboration, increasing access to historical images, and improving quality and efficiency through integration with laboratory information management systems. However, the resources to implement and operate a digital pathology system can be significant. Given the magnitude and risks involved in the decision to adopt digital histopathology, this working group used pertinent previously published survey results and its members’ expertise to create a Points-to-Consider article to assist organizations with building and implementing digital pathology workflows. With the aim of providing a comprehensive perspective, the current publication summarizes aspects of digital whole-slide imaging relevant to nonclinical histopathology evaluations, and then presents points to consider applicable to both primary digital histopathology evaluation and digital peer review in GLP toxicology studies. The Supplemental Appendices provide additional tabulated resources.

Publisher

SAGE Publications

Subject

Cell Biology,Toxicology,Molecular Biology,Pathology and Forensic Medicine

Reference44 articles.

1. Scientific and Regulatory Policy Committee Brief Communication: 2019 Survey on Use of Digital Histopathology Systems in Nonclinical Toxicology Studies

2. Part 58: Good Laboratory Practice for nonclinical laboratory studies. In: Code of Federal Regulations (CFR) Title 21. U.S. Food and Drug Administration; 1997. Accessed February 14, 2021, from the US FDA website: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=58

3. Part 792: Good Laboratory Practice Standards. In: Code of Federal Regulations (CFR) Title 40: Protection of the Environment. U.S. Environmental Protection Agency; 2011. Accessed February 14, 2021, from the US EPA website: https://www.epa.gov/compliance/good-laboratory-practices-standards-compliance-monitoring-program

4. Series on Principles of Good Laboratory Practice and Compliance Monitoring Number 1: Principles on Good Laboratory Practice. Organisation for Economic Co-operation and Development; 1998. Accessed February 14, 2021, from the OECD website: http://www.oecd.org/chemicalsafety/testing/oecdseriesonprinciplesofgoodlaboratorypracticeglpandcompliancemonitoring.htm

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3